InsidersTradesSigma
Total declarations
Company
▲ Purchases (14 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Medytox Inc.. Insider active across 1 companies, notably Evolus, Inc.. Aggregated, 14 disclosures have been recorded. Total volume traded: €6.8m. The latest transaction was filed on 27 August 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations14 total
€474,26751,000 shares@ €9.29940.11% mcap14.0% of flow
Common Stock, $0.00001 par value per share
SEC:0001387131-21-009158·
Ideal exit: 24 May 2022 (T+270)
€474,26751,000 shares@ €9.29940.11% mcap7.0% of flow
Common Stock, $0.00001 par value per share
SEC:0001387131-21-009158:0·
Ideal exit: 24 May 2022 (T+270)
€415,63544,000 shares@ €9.44630.096% mcap12.3% of flow
Common Stock, $0.00001 par value per share
SEC:0001387131-21-009024·
Ideal exit: 22 May 2022 (T+270)
€415,63544,000 shares@ €9.44630.096% mcap6.1% of flow
Common Stock, $0.00001 par value per share
SEC:0001387131-21-009024:0·
Ideal exit: 22 May 2022 (T+270)
€655,43369,781 shares@ €9.39270.15% mcap19.4% of flow
Common Stock, $0.00001 par value per share
SEC:0001387131-21-008933·
Ideal exit: 20 May 2022 (T+270)
€655,43369,781 shares@ €9.39270.15% mcap9.7% of flow
Common Stock, $0.00001 par value per share
SEC:0001387131-21-008933:0·
Ideal exit: 20 May 2022 (T+270)
€495,10255,000 shares@ €9.00190.11% mcap14.6% of flow
Common Stock, $0.00001 par value per share
SEC:0001387131-21-008879·
Ideal exit: 16 May 2022 (T+270)
€495,10255,000 shares@ €9.00190.11% mcap7.3% of flow
Common Stock, $0.00001 par value per share
SEC:0001387131-21-008879:0·
Ideal exit: 16 May 2022 (T+270)
€638,83770,000 shares@ €9.12620.15% mcap18.9% of flow
Common Stock, $0.00001 par value per share
SEC:0001387131-21-008746·
Ideal exit: 14 May 2022 (T+270)
€638,83770,000 shares@ €9.12620.15% mcap9.4% of flow
Common Stock, $0.00001 par value per share
SEC:0001387131-21-008746:0·
Ideal exit: 14 May 2022 (T+270)
€464,98249,714 shares@ €9.35310.11% mcap13.7% of flow
Common Stock, $0.00001 par value per share
SEC:0001387131-21-008661·
Ideal exit: 10 May 2022 (T+270)
€464,98249,714 shares@ €9.35310.11% mcap6.9% of flow
Common Stock, $0.00001 par value per share
SEC:0001387131-21-008661:0·
Ideal exit: 10 May 2022 (T+270)
€239,94226,160 shares@ €9.17210.056% mcap7.1% of flow
Common Stock, $0.00001 par value per share
SEC:0001387131-21-008519·
Ideal exit: 8 May 2022 (T+270)
€239,94226,160 shares@ €9.17210.056% mcap3.5% of flow
Common Stock, $0.00001 par value per share
SEC:0001387131-21-008519:0·
Ideal exit: 8 May 2022 (T+270)
14 of 14 declarations
About Medytox Inc.
Medytox Inc. is a director and insider at Evolus, Inc.
